163 related articles for article (PubMed ID: 36473177)
1. Identification and Prioritization of PET Neuroimaging Targets for Microglial Phenotypes Associated with Microglial Activity in Alzheimer's Disease.
Bartolo ND; Mortimer N; Manter MA; Sanchez N; Riley M; O'Malley TT; Hooker JM
ACS Chem Neurosci; 2022 Dec; 13(24):3641-3660. PubMed ID: 36473177
[TBL] [Abstract][Full Text] [Related]
2. Hippocampal glucose uptake as a surrogate of metabolic change of microglia in Alzheimer's disease.
Choi H; Choi Y; Lee EJ; Kim H; Lee Y; Kwon S; Hwang DW; Lee DS;
J Neuroinflammation; 2021 Aug; 18(1):190. PubMed ID: 34465358
[TBL] [Abstract][Full Text] [Related]
3. Imidazoline-I2 PET Tracers in Neuroimaging.
Parker CA; Nutt DJ; Tyacke RJ
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372936
[TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer's disease-related proteins.
Rangaraju S; Dammer EB; Raza SA; Gao T; Xiao H; Betarbet R; Duong DM; Webster JA; Hales CM; Lah JJ; Levey AI; Seyfried NT
Mol Neurodegener; 2018 Jun; 13(1):34. PubMed ID: 29954413
[TBL] [Abstract][Full Text] [Related]
5. Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging.
Hamelin L; Lagarde J; Dorothée G; Leroy C; Labit M; Comley RA; de Souza LC; Corne H; Dauphinot L; Bertoux M; Dubois B; Gervais P; Colliot O; Potier MC; Bottlaender M; Sarazin M;
Brain; 2016 Apr; 139(Pt 4):1252-64. PubMed ID: 26984188
[TBL] [Abstract][Full Text] [Related]
6. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
7. Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease.
Dani M; Wood M; Mizoguchi R; Fan Z; Walker Z; Morgan R; Hinz R; Biju M; Kuruvilla T; Brooks DJ; Edison P
Brain; 2018 Sep; 141(9):2740-2754. PubMed ID: 30052812
[TBL] [Abstract][Full Text] [Related]
8. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
[TBL] [Abstract][Full Text] [Related]
9. In vivo imaging of microglial activation by positron emission tomography with [(11)C]PBR28 in the 5XFAD model of Alzheimer's disease.
Mirzaei N; Tang SP; Ashworth S; Coello C; Plisson C; Passchier J; Selvaraj V; Tyacke RJ; Nutt DJ; Sastre M
Glia; 2016 Jun; 64(6):993-1006. PubMed ID: 26959396
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease.
Fan Z; Okello AA; Brooks DJ; Edison P
Brain; 2015 Dec; 138(Pt 12):3685-98. PubMed ID: 26510952
[TBL] [Abstract][Full Text] [Related]
11. Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer's disease.
Sobue A; Komine O; Hara Y; Endo F; Mizoguchi H; Watanabe S; Murayama S; Saito T; Saido TC; Sahara N; Higuchi M; Ogi T; Yamanaka K
Acta Neuropathol Commun; 2021 Jan; 9(1):1. PubMed ID: 33402227
[TBL] [Abstract][Full Text] [Related]
12. Classics in Neuroimaging: Untangling the Role of Tau in Neurodegenerative Disorders Using Positron Emission Tomography.
Witek JA; Brooks AF; Scott PJH
ACS Chem Neurosci; 2022 Oct; 13(19):2778-2783. PubMed ID: 36112411
[TBL] [Abstract][Full Text] [Related]
13. In vivo PET imaging of neuroinflammation in Alzheimer's disease.
Lagarde J; Sarazin M; Bottlaender M
J Neural Transm (Vienna); 2018 May; 125(5):847-867. PubMed ID: 28516240
[TBL] [Abstract][Full Text] [Related]
14. Imaging of Microglial Activation in Alzheimer's Disease by [
Donat CK; Mirzaei N; Tang SP; Edison P; Sastre M
Methods Mol Biol; 2018; 1750():323-339. PubMed ID: 29512083
[TBL] [Abstract][Full Text] [Related]
15. SPECT and PET imaging in Alzheimer's disease.
Valotassiou V; Malamitsi J; Papatriantafyllou J; Dardiotis E; Tsougos I; Psimadas D; Alexiou S; Hadjigeorgiou G; Georgoulias P
Ann Nucl Med; 2018 Nov; 32(9):583-593. PubMed ID: 30128693
[TBL] [Abstract][Full Text] [Related]
16. Molecular Targets for PET Imaging of Activated Microglia: The Current Situation and Future Expectations.
Tronel C; Largeau B; Santiago Ribeiro MJ; Guilloteau D; Dupont AC; Arlicot N
Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28398245
[TBL] [Abstract][Full Text] [Related]
17. Molecular Imaging of Neuroinflammation in Neurodegenerative Dementias: The Role of In Vivo PET Imaging.
Cerami C; Iaccarino L; Perani D
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475165
[TBL] [Abstract][Full Text] [Related]
18. Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer's Disease and Related Disorders.
Raji CA; Torosyan N; Silverman DHS
J Alzheimers Dis; 2020; 77(3):935-947. PubMed ID: 32804147
[TBL] [Abstract][Full Text] [Related]
19. Microglia in Alzheimer's Disease: An Unprecedented Opportunity as Prospective Drug Target.
Kulkarni B; Cruz-Martins N; Kumar D
Mol Neurobiol; 2022 May; 59(5):2678-2693. PubMed ID: 35149973
[TBL] [Abstract][Full Text] [Related]
20. Advances in proteomic phenotyping of microglia in neurodegeneration.
Sunna S; Bowen CA; Ramelow CC; Santiago JV; Kumar P; Rangaraju S
Proteomics; 2023 Jul; 23(13-14):e2200183. PubMed ID: 37060300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
